Collin K. Wells

Collin K. Wells

Auto-generated profile, based on publicly available information

Collin K. Wells

Center for Cardiometabolic Science, Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville ; Louisville, KY

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Redox Biology
Verified
Journal Article
Open access
RARiham Abouleisa
Riham Abouleisa
LMLindsey McNally
Lindsey McNally
ASAbou Bakr M. Salama
Abou Bakr M. Salama
SHSally K. Hammad
Sally K. Hammad
QOQinghui Ou
Qinghui Ou
BHBradford G. Hill
Bradford G. Hill
The coordinated gene and metabolic programs that facilitate cardiomyocyte entry and progression in the cell cycle are poorly understood. The purpose of this study was to identify the metabolic changes that influence myocyte proliferation. In adult mouse cardiomyocytes and human induced pluripotent stem cell cardiomyocytes (hiPS-CMs), cell cycle initiation by ectopic expression of Cyclin B1, Cyclin D1, CDK1, and CDK4 (termed 4F) downregulated oxidative phosphorylation genes and upregulated genes that regulate ancillary biosynthetic pathways of glucose metabolism. Results from metabolic analyses and stable isotope tracing experiments indicate that 4F-mediated cell cycle induction in hiPS-CMs decreases glucose oxidation and oxidative phosphorylation and augments NAD+, glycogen, hexosamine, phospholipid, and serine biosynthetic pathway activity. Interventions that diminish NAD+ synthesis, serine synthesis, or protein O-GlcNAcylation decreased 4F-mediated cell cycle entry. In a gain of function approach, we overexpressed phosphoenolpyruvate carboxykinase 2 (PCK2), which can drive carbon from the Krebs cycle to the glycolytic intermediate pool, and found that PCK2 augments 4F-mediated cell cycle entry. These findings suggest that a metabolic shift from catabolic to anabolic activity is a critical step for cardiomyocyte cell cycle entry and is required to facilitate proliferation.

29 April 2025 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
JSJonah K. Stephan
Jonah K. Stephan
TKTaylor Knerr
Taylor Knerr
CWCollin K. Wells
Collin K. Wells
ZGZhen Gu
Zhen Gu
SJSidney Renae Johnson
Sidney Renae Johnson
Marcin WysoczynskiMarcin Wysoczynski
Marcin Wysoczynski

13 December 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TJTyler Jobe
Tyler Jobe
JSJonah Stephan
Jonah Stephan
CWCollin K. Wells
Collin K. Wells
MSMaleesha De Silva
Maleesha De Silva
PLPawel K. Lorkiewicz
Pawel K. Lorkiewicz
Marcin WysoczynskiMarcin Wysoczynski
Marcin Wysoczynski
Neutrophils are a part of the innate immune system and produce reactive oxygen species (ROS) to extinguish pathogens. The major source of ROS in neutrophils is NADPH oxidase, which is fueled by NADPH generated via the pentose phosphate pathway; however, it is unclear how other accessory glucose metabolism pathways and mitochondrial activity influence the respiratory burst. We examined the temporal dynamics of the respiratory burst and delineated how metabolism changes over time after neutrophil activation. Bone marrow-derived neutrophils were stimulated with phorbol 12-myristate 13-acetate, and the respiratory burst was measured via extracellular flux analysis. Metabolomics experiments utilizing 13C6-glucose highlighted the activation of glycolysis as well as ancillary pathways of glucose metabolism in activated neutrophils. Phorbol 12-myristate 13-acetate stimulation acutely increased 13C enrichment into glycerol 3-phosphate (G3P) and citrate, whereas increases in 13C enrichment in the glycogen intermediate, UDP-hexose, and end products of the hexosamine and serine biosynthetic pathways occurred only during the late phase of the oxidative burst. Targeted inhibition of the G3P shuttle, glycogenolysis, serine biosynthesis, and mitochondrial respiration demonstrated that the G3P shuttle contributes to the general magnitude of ROS production; that glycogen contributes solely to the early respiratory burst; and that the serine biosynthetic pathway activity and complex III-driven mitochondrial activity influence respiratory burst duration. Collectively, these results show that the neutrophil oxidative burst is highly dynamic, with coordinated changes in metabolism that control the initiation, magnitude, and duration of ROS production.

26 May 2026 in Nature Communications
Verified
Journal Article
Open access
DNDaniel Nguyen
Daniel Nguyen
JSJonah K. Stephan
Jonah K. Stephan
LLLianay Gutierrez Luque
Lianay Gutierrez Luque
RBRobert E. Brainard
Robert E. Brainard
KBKenneth R. Brittian
Kenneth R. Brittian
BHBradford G. Hill
Bradford G. Hill
Organ function depends on communication among cell types to coordinate tissue growth and repair. Although fibroblasts are critical to this process, their role in regulating inflammatory responses to injury remain ambiguous. Here, we show that transforming growth factor β-activated kinase 1 (TAK1) is a gatekeeper of an inflammatory cardiac fibroblast phenotype. In cardiac fibroblasts, TAK1 signaling controls the acquisition of defining features of inflammatory fibroblasts, including chemokine and cytokine synthesis, lipid mediator production, metalloproteinase activity, and damage-associated molecular pattern recognition. Moreover, TAK1 propagates IL-1β and TNF-α signaling, but not TGF-β-SMAD signaling, regulating inflammatory programs by increasing chemokine secretion while decreasing lipid mediator production. Fibroblast-specific TAK1 deletion decreases neutrophil chemotaxis in vitro and immune cell recruitment after myocardial infarction in vivo, which is associated with improved cardiac remodeling and function in male mice. These results further resolve the nature and function of inflammatory fibroblasts in cardiac responses to injury and identify TAK1 signaling as a critical mediator.

18 September 2026 in Cardiovascular Research
Verified
Journal Article
Open access
ASAbou bakr Mohamed Salama
Abou bakr Mohamed Salama
QOQinghui Ou
Qinghui Ou
MDMarc Dwenger
Marc Dwenger
CWCollin K Wells
Collin K Wells
AGAhmad Gebreil
Ahmad Gebreil
TMTamer M A Mohamed
Tamer M A Mohamed
Aims: Adult cardiomyocytes (CMs) have minimal proliferative capacity, limiting the heart's ability to regenerate after injury. While neonatal CMs can proliferate, the signalling pathways governing this process are poorly understood. This study aims to identify and reintroduce the neonatal-specific CM proliferation sensitizing signal to restore cell cycle in adult CMs. Methods and results: We identified CD36 as a marker for the neonatal spontaneously proliferating CMs. Bulk and single cell RNA-seq, and spatial transcriptomics analyses of the P1 WT, CD36KO and CD36CKO hearts revealed that a CD36/FABP5/PPARδ signalling axis was uniquely expressed in spontaneously proliferating CMs. Using unbiased metabolomics and spatial metabolomics, we discovered that CD36KO and CD36cKO hearts had a 50% reduction in retinoic acid (RA) levels, implicating CD36 in regulating RA intracellular levels. Moreover, the pro-proliferative effect of RA treatment was lost in CD36KO or FABP5 knockdown CMs. To confirm the causality of this proposed mechanism, in vivo, crossing CD36KO with CM-specific PPARδ overexpression (PPARδCTG) only in CMs rescued the proliferation deficiency phenotype in CD36KO in the P1 hearts. Finally, reintroduction of FABP5, the rate limiting step of this signalling pathway, in adult hearts, using an inducible CM-specific FABP5 knock-in mouse (FABP5KI) was sufficient to drive CM cell-cycle entry and led to significantly improved cardiac function following myocardial infarction in adult mice. Conclusion: RA/CD36/FABP5/PPARδ signalling pathway is essential for spontaneous neonatal CM proliferation. Re-activating this pathway in adult hearts through FABP5 overexpression is sufficient to induce functional recovery after ischaemic injury, identifying FABP5 as a potential therapeutic target for cardiac regeneration.

12 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
BHBradford Hill
Bradford Hill
DNDaniel Nguyen
Daniel Nguyen
JSJonah Stephan
Jonah Stephan
RBRobert Brainard
Robert Brainard
KBKenneth Brittian
Kenneth Brittian
MWMarcin Wysoczynski
Marcin Wysoczynski
Organ health and function depend on communication between cell types to coordinate tissue growth and repair. Recent studies have indicated that fibroblasts are critical to this process; however, their role in regulating inflammatory responses to injury have remained ambiguous. Here, we demonstrate that transforming growth factor β-activated kinase 1 (TAK1) is a gatekeeper of the inflammatory cardiac fibroblast phenotype. We find that TAK1 propagates IL-1β and TNF-α signaling in cardiac fibroblasts and coordinates the synthesis and secretion of chemokines as well as inflammatory and pro-resolving lipid mediators. Deletion of TAK1 in fibroblasts decreased immune cell recruitment after MI, which was associated with improved cardiac structural and functional remodeling in male mice. Nevertheless, we found the effects of TAK1 deletion to be sexually dimorphic in nature, providing support to the idea that the protected phenotype of the female sex may be based in disparate immune and inflammatory responses. Moreover, TAK1 signaling controlled the acquisition of novel markers of the inflammatory fibroblast phenotype, having a biological basis in redox stress, chemokine and lipid mediator biosynthesis, metalloproteinase activity, and damage-associated molecular pattern recognition. Collectively, these results further resolve the nature and function of inflammatory cardiac fibroblasts in cardiac responses to injury and identify TAK1 signaling in fibroblasts as a potential target for therapy.